Audited Results of Caplin Point Laboratories Ltd. Company

(Rs in Cr.)	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Operating Income	738.33	752.41	625.09	528.61	528.06
Manufacturing Expenses	0	14.11	15.43	9.89	10.68
Personnel Expenses	47.72	52.13	38.11	36.68	30.47
Selling Expenses	0	0	0	0	0
Administrative Expenses	123.87	116.03	79.25	64.06	62.64
Expenses Capitalised	0	0	0	0	0
Cost Of Sales	400.55	420.44	338.01	308.69	308.44
Operating Profit	337.78	331.97	287.08	219.92	219.62
Other Recurring Income	195.37	134.59	105.84	99	56.55
Adjusted PBDIT	533.15	466.56	392.92	318.92	276.17
Financial Expenses	0.20	0.12	0.10	0.12	0.09
Depreciation	25.43	24.77	27.08	25.65	25.77
Other Write offs	0	0	0	0	0
Adjusted PBT	507.52	441.67	365.74	293.15	250.31
Tax Charges	110.94	102.18	82.03	58.89	62.44
Adjusted PAT	396.58	339.49	283.71	234.26	187.87
Non Recurring Items	0	0	0	0	0.10
Other Non Cash adjustments	0	0	0	0	0
Reported Net Profit	396.58	339.49	283.71	234.26	187.87
Equity Dividend	0	37.99	34.17	30.32	0
Preference Dividend	0	0	0	0	0
Retained Earnings	396.58	1,634.99	1,333.49	1,083.95	902.90

Disclaimer: This is 3rd Party content/feed, viewers are requested to use their discretion and conduct proper diligence before investing, GoodReturns does not take any liability on the genuineness and correctness of the information in this article